Regulation of Survival, Dormancy and Resuscitation in Mycobacterium; Understanding the Role of Ribosome-Associated Factors
Implementing Organization
Jadavpur University
Principal Investigator
Dr. Sandip Dey
Jadavpur University
About
Mycobacterium tuberculosis affects 33% of the global population, with 1.8 billion people carrying latent infection. In latent infection, Mycobacterium cells alter their morphology and physiology to survive in low oxygen environments for decades. They can return to an active form and cause infection under immunocompromised conditions. Two DosR (dormancy survival regulon) regulated proteins, RafH and RafS, and HflX (a conserved GTPase), play a crucial role in maintaining dormant cell homeostasis by interacting with ribosomes and ribosomal subunits. RafH and RafS interact with ribosomes to create inactivated 70S ribosomes, while HflX splits vacant ribosomes into ribosomal subunits and imposes anti-association effects on both subunits. Mycobacterium cells slow down ribosomal RNA transcription, overall translation, and stabilize their ribosomes during dormancy. These methods include inactivation of ribosomes, promotion of specific mRNA translation, and stabilization of ribosomes. HflX, a known ribosome splitter, can restore ribosomes from inactive 100S dimers in Staphylococcus, but Mycobacterium imposes inactivation of ribosomes as 70S particles are not in 100S form. To withdraw inactivation effects, HflX should interact with RafH or RafS inactivated 70S ribosomes and split the complex to initiate translation. Recent studies have shown that Mycobacterium RafH and RafS bind near the decoding center of 30S subunit and prevent mRNA entry. The binding strategy of Mycobacterium HflX and ribosome or ribosomal subunits is not yet known.
Source
Source
Anusandhan National Research Foundation/Science and Engineering Research Board (SERB), DST 2023-24
Science and Engineering Research Board (SERB), New Delhi
Anusandhan National Research Foundation (ANRF)
Quick Information
Area of Research
Life Sciences & Biotechnology
Start Year
2024
End Year
2026
Status
Ongoing
Contact
sandip6bot@gmail.com
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
00
No. of Patents
Filed :00
Grant :00
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.